Calendar Roivant Sciences Ltd.

Equities

ROIV

BMG762791017

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-20 pm EDT			5-day change	1st Jan Change
11.45 ^USD	+0.09%		+1.15%	-3.21%

Jun. 10	Roivant Sciences Ltd. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 04:00 PM
Jun. 06	Roivant Sciences Insider Sold Shares Worth $8,454,808, According to a Recent SEC Filing	MT

Chart calendar Roivant Sciences Ltd.

59502cf744007f402c0873c1.t7KDCBC81UKPYHxe3Z92EuirEXMyliA5SLf2EDSUXtM._N_mbHrzkiX5NwYP7-kRVJzGYDtB2lZPO8OlRWClGbXvgLNLZv29JusvNQ~39cc90a55f4b78fd727f55304269be6d

Upcoming events on Roivant Sciences Ltd.

2025-08-17	Q1 2025 Earnings Release (Projected)
2025-11-16	Q2 2025 Earnings Release (Projected)
2026-02-15	Q3 2025 Earnings Release (Projected)
2026-06-30	Q4 2025 Earnings Release (Projected)

Past events on Roivant Sciences Ltd.

2025-06-17 01:00 pm	Phase 3 Brepocitinib’s VALOR Update Call
2025-06-10 04:00 pm	Goldman Sachs Global Healthcare Conference
2025-06-05 04:20 pm	Jefferies Healthcare Conference
2025-06-01	Investor Meeting
2025-05-29 08:00 am	Q4 2025 Earnings Call
2025-05-29 07:00 am	Q4 2024 Earnings Release
2025-05-14 07:20 pm	Bank of America Global Healthcare Conference
2025-04-27	Investor Meeting
2025-04-21 08:00 am	Executive Update Call
2025-03-26	Investor Meeting
2025-03-19 08:00 am	Phase 3 study of batoclimab in MG and Phase 2b study in CIDP Update Call
2025-03-10 10:40 am	Leerink Partners Global Healthcare Conference
2025-03-04 01:10 pm	TD Cowen Healthcare Conference
2025-02-10 08:00 am	Q3 2024 Earnings Call
2025-02-10 07:00 am	Q3 2024 Earnings Release
2025-02-05 03:00 pm	Guggenheim Securities SMID Cap BioTech Conference
2025-01-13 05:15 pm	JP Morgan Healthcare Conference
2024-12-04 02:10 pm	Evercore ISI HealthCONx Conference
2024-11-19 11:00 am	Jefferies London Healthcare Conference
2024-11-12 08:00 am	Q2 2024 Earnings Call

Annual results

Fiscal Period	March	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	61,3 52,3 17.2%	125 662 -81.14%	29,1 141 -79.44%	29,2	43,5	506
EBITDA Million USD	Released Forecast Spread	-1 156 -1 190 2.8%	-1 084 -1 071 -1.28%	-996 -954 -4.45%	-1 368	-1 304	-709
EBIT Million USD	Released Forecast Spread	-1 175 -1 170 -0.41%	4 242 1 608 163.75%	-1 003 -979 -2.49%	-1 110	-1 206	-886
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-1 225 -1 313 6.71%	4 253 4 176 1.87%	-682 -592 -15.17%	-1 043	-1 176	-847
Net income Million USD	Released Forecast Spread	-1 009 -1 216 16.99%	4 349 4 261 2.07%	-172 -106 -62.71%	-896	-1 041	-756
EPS USD	Released Forecast Spread	-1,42 -1,71 17.02%	5,23 5,18 0.99%	-0,24 -0,33 27.27%	-1,34	-1,50	-1,17
Announcement Date		28/06/23	30/05/24	29/05/25	-

Quarterly results

Fiscal Period	March	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million USD	Released Forecast Spread	37,1 27,1 36.82%	37,1 29,8 24.53%	28,9 30,9 -6.51%	55,1 29,6 86.33%	29,3 55,4 -47.16%	9,02 9,20 -1.98%	7,57 62,2 -87.82%	7,16	7,26	7,52	7,76	6,00	6,00	6,00	6,00
EBITDA Million USD	Released Forecast Spread	-271 -264 -2.5%	-282 -265 -6.51%	-261 -240 -8.52%	-115 -281 58.97%	-337 -130 -158.4%	-271 -306 11.29%	-284 -218 -30.08%	-305	-318	-348	-397
EBIT Million USD	Released Forecast Spread	-276 -257 -7.63%	5 061 -267 1992.11%	-266 -285 6.65%	-120 -255 52.95%	-342 -373 8.5%	-274 -283 3.09%	-285 -216 -31.81%	-259	-272	-278	-296	-236	-241	-247	-252
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-327 -249 -31.46%	5 098 -279 1929.33%	-191 -276 30.57%	70,1 -235 129.88%	-224 -218 -2.99%	-235 -241 2.62%	-203 -153 -32.76%	-247	-263	-273	-294
Net income Million USD	Released Forecast Spread	-304 -225 -34.98%	5 096 -255 2094.89%	-151 -248 39.06%	95,3 -207 146%	-230 -164 -40.78%	169 -222 176.38%	-206 -140 -47.14%	-203	-216	-223	-239
EPS USD	Released Forecast Spread	-0,40 -0,31 -30.84%	6,03 0,49 1140.1%	-0,19 -0,30 35.75%	0,12 -0,26 146.45%	-0,31 -0,25 -25.27%	0,23 -0,28 180.72%	-0,29 -0,22 -34.26%	-0,26	-0,36	-0,35	-0,37
Announcement Date		13/11/23	13/02/24	30/05/24	08/08/24	12/11/24	10/02/25	29/05/25	-	-	-	-	-	-	-	-

Upcoming sector events for Roivant Sciences Ltd.

2025-07-09	HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
2025-07-15	GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected)
2025-07-16 06:45 am	JOHNSON & JOHNSON: Q2 2025 Earnings Release
2025-07-16	NOVARTIS AG: Q2 2025 Earnings Release
2025-07-16	CAMURUS AB: Q2 2025 Earnings Release
2025-07-17	JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected)
2025-07-18 05:00 am	ORION OYJ: Q2 2025 Earnings Release
2025-07-22	LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected)
2025-07-22	TILRAY BRANDS, INC.: Q4 2025 Earnings Release (Projected)
2025-07-22	GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Roivant Sciences Ltd.

2025-06-17 11:45 am	MEDINCELL S.A.: Q4 2025 Earnings Release
2025-06-10 04:38 am	LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release
2025-06-09 04:48 am	YUNGSHIN GLOBAL HOLDING CORPORATION: May 2025 Sales and Revenue Release
2025-06-08 08:01 pm	BORA PHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release
2025-06-06 04:47 am	CALIWAY BIOPHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release
2025-06-05 04:37 am	TTY BIOPHARM COMPANY LIMITED: May 2025 Sales and Revenue Release
2025-06-03 04:35 am	ONENESS BIOTECH CO., LTD.: May 2025 Sales and Revenue Release
2025-05-30 09:46 am	ASTRAZENECA PHARMA INDIA LIMITED: Q4 2025 Earnings Release
2025-05-29 07:00 am	ROIVANT SCIENCES LTD.: Q4 2024 Earnings Release
2025-05-29 04:31 am	ALKEM LABORATORIES LIMITED: Q4 2025 Earnings Release